Hormone Treatment without Surgery for Patients Aged 75 Years or Older with Operable Breast Cancer

C. J. Wink,K. Woensdregt,G.A.P. Nieuwenhuijzen,M.J.C. van der Sangen,S. Hutschemaekers,Jan A. Roukema,Vivianne C. G. Tjan-Heijnen,Adri C. Voogd

Hormone Treatment without Surgery for Patients Aged 75 Years or Older with Operable Breast Cancer

2012

C. J. Wink
K. Woensdregt
G.A.P. Nieuwenhuijzen
M.J.C. van der Sangen
S. Hutschemaekers
Jan A. Roukema
Vivianne C. G. Tjan-Heijnen
Adri C. Voogd

Purpose To evaluate the trend in the use of primary endocrine treatment (PET) for elderly patients with operable breast cancer and to study mean time to response (TTR), local control, time to progression (TTP), and overall survival.

Keywords:

Breast cancer
Hormone
Anastrozole
Endocrine system
Tamoxifen
Aromatase inhibitor
Survival rate
Oncology
Internal medicine
Medicine
time to progression

Correction
Source
Cite
Save
Machine Reading By IdeaReader

References

Citations